Self-injectable therapies face a critical drop-off between prescription and adherence. Despite significant investment in patient support, many patients abandon treatment due to lack of training and confidence. Specialty pharmacies are under pressure to improve first-fill rates and outcomes, yet most patients receive no hands-on guidance at dispense—putting brand performance and patient health at risk.
This session introduces SureStartRx (SSRx), a pharma-funded training solution delivered through specialty pharmacies. SSRx provides patients with a realistic training device and digital education at first dose, helping bridge the gap between dispense and adherence. We’ll share pilot insights and show how SSRx supports patient onboarding and engagement.
Learn how SSRx can enhance channel strategy, trade relations, and patient support. Discover how to drive better adherence, improve refill rates, and generate real-world data to strengthen payer value propositions—all through specialty pharmacy collaboration.
Join us for Bridging Dispense and Adherence with Specialty Pharmacy and explore how SSRx is transforming patient engagement. Register now to reserve your spot and be part of the future of specialty pharmacy innovation.
Key Learning Objectives
- Understand the critical role of specialty pharmacy at the moment of dispense and how missed opportunities in patient onboarding contribute to poor adherence and therapy abandonment in self-injectable treatments.
- Explore the SureStartRx (SSRx) program as a scalable solution that delivers hands-on training and digital education to patients, improving confidence, engagement, and refill rates.
- Learn how SSRx supports market access, channel strategy, and trade relations goals by generating real-world evidence, enhancing patient outcomes, and strengthening specialty pharmacy partnerships.
Other Webinars
